NanoString Technologies, Inc.
Compare this stock
NSTG Stock Report Card
$
33%
Performance
Score:
10/100
NSTG returned -82.21% in the last 12 months. Based on SPY's performance of -12.72%, its performance is below average giving it a score of 10 of 100.
Analyst Price Targets
Score:
65/100
5 analysts offer 12-month price targets for NSTG. Together, they have an average target of 0, the most optimistic target put NSTG at 0 within 12-months and the most pessimistic has NSTG at 0.
Sentiment
Score:
71/100
NSTG had a bullish sentiment score of 70.90% across Twitter and StockTwits over the last 12 months. It had an average of 3.53 posts, 0.87 comments, and 4.33 likes per day.
Technicals
Score:
36/100
NSTG receives a 35 of 100 based on 14 indicators. 4 are bullish, 8 are bearish.
Earnings
Score:
10/100
NSTG has missed earnings 16 times in the last 20 quarters.
Profit
Score:
10/100
Out of the last 20 quarters, NSTG has had 1 profitable quarters and has increased their profits year over year on 0 of them.
Volatility
Score:
44/100
NSTG has had a lower than average amount of volatility over the last 12 months giving it a score of 43 of 100.
NanoString Technologies, Inc. Summary
Nasdaq / NSTG
Healthcare
Medical Instruments & Supplies
NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics. It has collaboration with Lam Research Corporation for the research and development of Hyb & Seq technologies; Celgene Corporation for developing LymphMark, an in vitro diagnostic for the treatment of diffuse large B-cell lymphoma; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Checkout Similar Companies
NSTG scored poorly on our reportcard. Here are some similar companies and how they performed.
